Moderna seeks EU authorisation for Covid-19 vaccine in young kids
Moderna Inc said on Tuesday it has submitted for a variation to the conditional marketing authorisation with the European Medicines Agency for the evaluation of its Covid-19 vaccine's use in children in the age-group of 6-11 years